1. Alexion says “no” to investor proactive sale demand — FDA approves first copycats of Novartis MS drug Gilenya — $178M stockpile of Merck ebola vaccine authorized — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Pharma/Biotech Companies - Compliance

General discussion board for pharma/biotech compliance


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    2
    Views:
    3,352
  2. Anonymous
    Replies:
    3
    Views:
    3,917
  3. anonymous
    Replies:
    1
    Views:
    1,234
  4. anonymous
    Replies:
    4
    Views:
    2,583
  5. cafepharma915
    Replies:
    0
    Views:
    990
  6. anonymous
    Replies:
    7
    Views:
    5,842
  7. anonymous
    Replies:
    12
    Views:
    6,405
  8. P T Barnum
    Replies:
    0
    Views:
    967
  9. Anonymous
    Replies:
    18
    Views:
    7,029
  10. anonymous
    Replies:
    3
    Views:
    3,179
  11. Eyesonyou
    Replies:
    3
    Views:
    3,567
  12. anonymous
    Replies:
    0
    Views:
    2,463
  13. Anonymous
    Replies:
    6
    Views:
    5,064
  14. RobertPhillips900
    Replies:
    0
    Views:
    1,129
  15. Modern Medicine
    Replies:
    18
    Views:
    9,694
  16. anonymous
    Replies:
    2
    Views:
    3,209
  17. Anonymous
    Replies:
    1
    Views:
    3,215
  18. anonymous
    Replies:
    0
    Views:
    2,527
  19. Jessie Maddox
    Replies:
    0
    Views:
    4,654
  20. anonymous
    Replies:
    2
    Views:
    2,922

Thread Display Options

Loading...